Skip to article
Astra

Hypertension

Secondary Hypertension

Identify secondary hypertension when presentation, treatment resistance, or target-organ injury suggests a remediable cause; confirm true resistance, remove iatrogenic contributors, then prioritize renal disease, primary aldosteronism, obstructive sleep apnea, renovascular disease, and selected endocrine disorders.

Clinical question: How should clinicians prioritize evaluation for treatable causes of secondary hypertension in adults?

First decision

Identify presentations that warrant a secondary-cause pathway

Escalate beyond routine primary-hypertension management when the phenotype implies a reversible cause or immediate end-organ risk.

Prioritize a secondary-hypertension evaluation in patients younger than 40 years, those with sudden worsening or accelerated hypertension, and those with blood pressure that responds poorly to treatment. Accelerated hypertension with blood pressure above 180/110 mm Hg plus papilledema and/or retinal hemorrhage requires urgent assessment rather than deferred outpatient etiologic testing. nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...AHA JournalsPrevalence and Risk Factors for Secondary Hypertension ...

For severe blood-pressure elevation, first determine whether acute end-organ damage is present and obtain renal function, electrolytes, bicarbonate, glucose, HbA1c, lipids, complete blood count, clotting studies when microangiopathic hemolytic anemia or disseminated intravascular coagulation is a concern, urine microscopy, urine albumin-to-creatinine ratio, and thyroid function tests. NatureManagement of hypertensive crisis: British and Irish ...

During a hypertensive crisis, collect endocrine studies selectively and interpret them cautiously. Pressure natriuresis with volume depletion can produce secondary hyperaldosteronism, while medications, pain, anxiety, subarachnoid hemorrhage-related stress, heart failure, and kidney failure can make renin, aldosterone, and metanephrine results unreliable; complete elective secondary-cause testing after stabilization when possible. NatureManagement of hypertensive crisis: British and Irish ...

Clinical patterns that should redirect evaluation toward secondary hypertension. jaccResistant Hypertension: An Overview of Evaluation and TreatmentScienceDirectEvaluations of secondary hypertension and laboratory data in the elderly populationnice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...AHA JournalsPrevalence and Risk Factors for Secondary Hypertension ...
Clinical triggerPriority diagnostic directionImmediate next action
Hypertension before age 40 yearsBroad secondary-cause screenEvaluate renal, renovascular, endocrine, sleep-related, and drug-induced contributors. ScienceDirectEvaluations of secondary hypertension and laboratory data in the elderly populationAHA JournalsPrevalence and Risk Factors for Secondary Hypertension ...
Accelerated hypertension or BP >180/110 mm Hg with papilledema or retinal hemorrhageAcute end-organ injury and secondary causesUrgently assess renal, hematologic, urinary, metabolic, and thyroid abnormalities; stabilize before interpreting confounded endocrine results. NatureManagement of hypertensive crisis: British and Irish ...nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...
Resistant hypertensionPrimary aldosteronism, renal disease, renovascular disease, obstructive sleep apnea, and medication/substance contributorsScreen for primary aldosteronism regardless of potassium concentration and systematically assess common coexisting causes. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...AHA JournalsResistant Hypertension: Detection, Evaluation, and ...jaccResistant Hypertension: An Overview of Evaluation and Treatment
Episodic or clinically suspicious catecholamine-excess phenotypePheochromocytoma/paragangliomaMeasure plasma and/or urinary metanephrines and arrange urgent specialty-directed evaluation. NatureManagement of hypertensive crisis: British and Irish ...nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...

Before testing

Exclude modifiable mimics of resistant hypertension

Correct removable pressure-raising exposures and volume contributors before attributing uncontrolled blood pressure to a rare disorder.

Perform a structured reconciliation of prescription drugs, over-the-counter agents, supplements, recreational drugs, alcohol, and dietary exposures. Important causes include NSAIDs including COX-2 inhibitors, sympathomimetic decongestants and anorectics, cocaine, amphetamines, oral contraceptive hormones, adrenal steroid hormones, erythropoietin, cyclosporine, tacrolimus, licorice-containing products, and supplements containing ginseng, yohimbine, ma huang, or bitter orange. jaccResistant Hypertension: An Overview of Evaluation and Treatment

Assess sodium exposure, extracellular-volume status, kidney disease, and adequacy of diuretic therapy. Excess sodium intake, volume retention from kidney disease, and inadequate diuresis can maintain apparent resistant hypertension and should be corrected in parallel with etiologic testing. jaccResistant Hypertension: An Overview of Evaluation and Treatment

Actively assess obesity, diabetes, and obstructive sleep apnea in resistant hypertension. Obstructive sleep apnea is a common secondary cause associated with resistant hypertension, and its coexistence does not exclude renal, renovascular, or endocrine causes. AHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...AHA JournalsResistant Hypertension: Detection, Evaluation, and ...jaccResistant Hypertension: An Overview of Evaluation and Treatment

Reversible contributors to address before expanding low-pretest-probability endocrine testing. jaccResistant Hypertension: An Overview of Evaluation and Treatment
ContributorExamplesClinical action
Medication-related blood-pressure elevationNSAIDs, COX-2 inhibitors, sympathomimetics, oral contraceptives, corticosteroids, erythropoietin, cyclosporine, tacrolimus jaccResistant Hypertension: An Overview of Evaluation and TreatmentStop, substitute, or minimize the implicated exposure when clinically feasible; reassess blood pressure response. jaccResistant Hypertension: An Overview of Evaluation and Treatment
Substance or supplement exposureCocaine, amphetamines, excess alcohol, licorice, ginseng, yohimbine, ma huang, bitter orange jaccResistant Hypertension: An Overview of Evaluation and TreatmentObtain a nonjudgmental exposure history and discontinue the causative product. jaccResistant Hypertension: An Overview of Evaluation and Treatment
Sodium and volume excessExcess sodium intake, kidney-disease-associated volume retention, inadequate diuretic therapy jaccResistant Hypertension: An Overview of Evaluation and TreatmentCorrect sodium and volume contributors while evaluating kidney disease. jaccResistant Hypertension: An Overview of Evaluation and Treatment
Sleep-disordered breathingObstructive sleep apnea AHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...jaccResistant Hypertension: An Overview of Evaluation and TreatmentPursue sleep-focused evaluation when symptoms or resistant hypertension indicate risk. AHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...jaccResistant Hypertension: An Overview of Evaluation and Treatment

Targeted workup

Match testing to the most actionable etiologic branch

Use clinical phenotype and initial kidney, urine, endocrine, and sleep findings to sequence confirmatory testing.

Renal parenchymal disease is the most common medical cause of secondary hypertension in resistant-hypertension evaluations. Abnormal renal function, urine microscopy, or urine albumin-to-creatinine ratio should direct the next diagnostic step toward kidney disease rather than an isolated endocrine workup. NatureManagement of hypertensive crisis: British and Irish ...jaccResistant Hypertension: An Overview of Evaluation and Treatment

Consider renovascular disease when the overall clinical setting suggests renal arterial disease, particularly in resistant hypertension. Renal artery stenosis is among the common identifiable causes in this setting; renal artery and kidney imaging should be directed by clinical suspicion rather than used as a universal screen. NatureManagement of hypertensive crisis: British and Irish ...jaccResistant Hypertension: An Overview of Evaluation and Treatment

Primary aldosteronism is a high-priority, treatment-changing diagnosis. It occurs in approximately 5% to 10% of all hypertension and about 20% of resistant hypertension, and the 2025 AHA/ACC guideline recommends screening adults with resistant hypertension regardless of whether hypokalemia is present. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...

Use the plasma aldosterone-to-renin ratio as the screening test for primary aldosteronism in patients with hypertension, including those without hypokalemia. A positive screen generally requires confirmation of inappropriate aldosterone secretion with a suppression test such as saline infusion or fludrocortisone suppression before subtype-directed management. NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexAHA JournalsRenin Ratio Cutoff for Primary Aldosteronism | Hypertension

Etiology-directed diagnostic branches for secondary hypertension. NatureManagement of hypertensive crisis: British and Irish ...NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexjaccResistant Hypertension: An Overview of Evaluation and TreatmentScienceDirectEvaluations of secondary hypertension and laboratory data in the elderly populationendocrinePrimary AldosteronismAHA JournalsRenin Ratio Cutoff for Primary Aldosteronism | Hypertension
Etiologic branchClues or initial findingsFocused test or next stepManagement implication
Renal parenchymal diseaseAbnormal renal function, urine microscopy, or urine albumin-to-creatinine ratio NatureManagement of hypertensive crisis: British and Irish ...jaccResistant Hypertension: An Overview of Evaluation and TreatmentDirect evaluation to kidney disease after abnormal initial renal and urine testing. NatureManagement of hypertensive crisis: British and Irish ...jaccResistant Hypertension: An Overview of Evaluation and TreatmentAddress kidney-associated volume retention and optimize diuretic therapy. jaccResistant Hypertension: An Overview of Evaluation and Treatment
Renovascular diseaseResistant hypertension with a clinical setting suggestive of renal arterial disease AHA JournalsResistant Hypertension: Detection, Evaluation, and ...jaccResistant Hypertension: An Overview of Evaluation and TreatmentObtain renal artery and kidney imaging when suspicion is sufficient. NatureManagement of hypertensive crisis: British and Irish ...Define renovascular disease within a specialist-directed treatment plan. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...AHA JournalsResistant Hypertension: Detection, Evaluation, and ...
Primary aldosteronismResistant hypertension, with or without hypokalemia AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...AHA JournalsRenin Ratio Cutoff for Primary Aldosteronism | HypertensionScreen with aldosterone-to-renin ratio; confirm inappropriate secretion with saline infusion or fludrocortisone suppression when indicated. NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexAHA JournalsRenin Ratio Cutoff for Primary Aldosteronism | HypertensionUse adrenal vein sampling for functional localization when subtype classification will direct treatment. NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature Index
Obstructive sleep apneaResistant hypertension or sleep-symptom phenotype AHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...jaccResistant Hypertension: An Overview of Evaluation and TreatmentPerform sleep-focused clinical assessment and formal evaluation when indicated. AHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...Treat sleep-disordered breathing as a contributing cause while evaluating coexisting secondary etiologies. AHA JournalsResistant Hypertension: Detection, Evaluation, and ...jaccResistant Hypertension: An Overview of Evaluation and Treatment
Pheochromocytoma/paragangliomaClinical suspicion for catecholamine excess NatureManagement of hypertensive crisis: British and Irish ...nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...Measure plasma and/or urinary metanephrines. NatureManagement of hypertensive crisis: British and Irish ...Arrange urgent specialty evaluation; definitive treatment is surgical tumor removal. nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...
Cushing syndrome or thyroid diseaseCompatible clinical phenotype or abnormal thyroid testing NatureManagement of hypertensive crisis: British and Irish ...ScienceDirectRenal Hypertension - an overviewTest for Cushing syndrome when clinically suspected; obtain thyroid function tests in severe hypertension. NatureManagement of hypertensive crisis: British and Irish ...Treat the identified endocrine disorder rather than escalating antihypertensive therapy alone. ScienceDirectEvaluations of secondary hypertension and laboratory data in the elderly populationScienceDirectRenal Hypertension - an overview

Primary aldosteronism

Primary aldosteronism should not be limited to the classic hypokalemic phenotype. Bilateral adrenal hyperplasia accounts for approximately two-thirds of cases, while about one-third have unilateral aldosterone overproduction from an aldosterone-producing adenoma, less often unilateral hyperplasia, and rarely adrenal carcinoma. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...

Refer for multidisciplinary endocrine, radiology, and surgical evaluation once biochemical testing supports primary aldosteronism and a patient is a potential procedural candidate. The key management decision is functional laterality: unilateral disease supports laparoscopic adrenalectomy, whereas bilateral disease supports medical mineralocorticoid receptor antagonism. NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexendocrinePrimary Aldosteronism

Cause-directed care

Link diagnosis to definitive treatment and follow-up

The value of testing is highest when the result changes a durable intervention, not simply the antihypertensive drug count.

For primary aldosteronism, treatment selection follows subtype. Laparoscopic adrenalectomy is the preferred definitive therapy for unilateral aldosterone-producing adenoma and often cures or markedly improves hypertension; bilateral disease is treated medically with mineralocorticoid receptor antagonists. The Endocrine Society suggests spironolactone over alternative medical therapy for patients receiving primary-aldosteronism-specific treatment. NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexendocrinePrimary Aldosteronism

Use specialist referral early for suspected primary aldosteronism, pheochromocytoma/paraganglioma, Cushing syndrome, or renovascular hypertension because testing and treatment require technical interpretation and, in selected cases, specialized procedures. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...

Follow treatment response using blood pressure, serum potassium when mineralocorticoid excess or antagonism is relevant, and kidney function during management of kidney disease or mineralocorticoid receptor antagonist therapy. In primary aldosteronism, reassess blood-pressure control and biochemical abnormalities after medical therapy or adrenalectomy because cure is not universal even after treatment of unilateral disease. NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexendocrinePrimary Aldosteronism

Treatment decisions that depend on etiologic confirmation. AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexendocrinePrimary Aldosteronismnice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...
Confirmed diagnosisDefinitive or disease-specific strategyKey decision point
Unilateral primary aldosteronismLaparoscopic adrenalectomy NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexEstablish functional laterality with adrenal vein sampling when subtype classification will determine surgery. NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature Index
Bilateral primary aldosteronismMedical mineralocorticoid receptor antagonism; spironolactone is suggested by the Endocrine Society. endocrinePrimary AldosteronismUse medical therapy when aldosterone excess is bilateral rather than surgically lateralized. NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexendocrinePrimary Aldosteronism
Pheochromocytoma/paragangliomaSurgical tumor removal is definitive treatment. nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...Proceed through urgent specialist investigation after clinical suspicion and metanephrine testing. NatureManagement of hypertensive crisis: British and Irish ...nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...
Drug- or substance-induced hypertensionWithdrawal, substitution, or reduction of the causative exposure jaccResistant Hypertension: An Overview of Evaluation and TreatmentReassess blood pressure after eliminating the identified contributor. jaccResistant Hypertension: An Overview of Evaluation and Treatment

References

  1. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...www.ahajournals.org · www.ahajournals.org
  2. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...www.ahajournals.org · www.ahajournals.org
  3. Resistant Hypertension: Detection, Evaluation, and ...www.ahajournals.org · www.ahajournals.org
  4. Resistant Hypertension: Diagnosis, Evaluation, and ...www.ahajournals.org · www.ahajournals.org
  5. Management of hypertensive crisis: British and Irish ...www.nature.com · www.nature.com
  6. Primary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature Indexwww.nature.com · www.nature.com
  7. Recognize, Monitor, Treat: A Comprehensive Approach to Improving Resistant Hypertension Carewww.jacc.org · www.jacc.org
  8. Resistant Hypertension: An Overview of Evaluation and Treatmentwww.jacc.org · www.jacc.org
  9. Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Designwww.jacc.org · www.jacc.org
  10. Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Reviewwww.jacc.org · www.jacc.org
  11. Spectrum of Hyperaldosteronism, Opportunities for Diagnosiswww.acpjournals.org · www.acpjournals.org
  12. Evaluations of secondary hypertension and laboratory data in the elderly populationwww.sciencedirect.com · www.sciencedirect.com
  13. Evaluation and Management of Secondary Hypertensionwww.sciencedirect.com · www.sciencedirect.com
  14. Renal Hypertension - an overviewwww.sciencedirect.com · www.sciencedirect.com
  15. Review Diagnosis and treatment of primary aldosteronismwww.sciencedirect.com · www.sciencedirect.com
  16. Diagnosing endocrine hypertension: a practical approachonlinelibrary.wiley.com · onlinelibrary.wiley.com
  17. Diagnosis and treatment of primary aldosteronism: ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  18. Endocrine Society guideline calls for increased screening for common cause of high blood pressure | Endocrine Societywww.endocrine.org · www.endocrine.org
  19. Primary Aldosteronismwww.endocrine.org · www.endocrine.org
  20. NATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...www.nice.org.uk · www.nice.org.uk
  21. Prevalence and Risk Factors for Secondary Hypertension ...www.ahajournals.org · www.ahajournals.org
  22. Primary Aldosteronism | Circulationwww.ahajournals.org · www.ahajournals.org
  23. Clinical Management of Primary Aldosteronism: An Updatewww.ahajournals.org · www.ahajournals.org
  24. Renin Ratio Cutoff for Primary Aldosteronism | Hypertensionwww.ahajournals.org · www.ahajournals.org